Lab grown bile duct organoids could restore liver health in humans
Medical Xpress - 18-Feb-2021Cholangiocyte-based therapy repairs bile ducts, offers hope to repair damaged donor livers
Previously the Live Forever Club – now more focused on campaigning for radical life extension in the UK
Physician in hepatology and researcher at Wellcome-MRC Cambridge Stem Cell Institute
Fotios Sampaziotis received his M.D. from the University of Athens in Greece followed by clinical training in the UK. During his clinical training he obtained a Ph.D. in stem cell biology from the University of Cambridge. He has pioneered the use of bile duct organoids to model diseases of the biliary system, test multiple drugs, and identify new therapeutic agents. Currently, Fotios’ research takes place at the interface between basic science and clinical medicine at Cambridge university where he also works as a physician in hepatology at Addenbrooke's Hospital. His scientific work focuses on combining organoids, bioengineering, and animal studies to regenerate damaged bile ducts in the liver as an alternative therapy to liver transplantation.
Details last updated 20-Feb-2021
Cholangiocyte-based therapy repairs bile ducts, offers hope to repair damaged donor livers